This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
ADDERALL 10 MG TABLET is a brand (anda) product labeled by Teva Pharmaceuticals USA Inc., priced at $12.1878 per EA under NDC 57844011001. Its NADAC has been published 655 times since Mar 19, 2014.
FDA first approved this application on Feb 11, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
ADDERALL 10 MG TABLET
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
57844011001
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040422FDA Approved
2/11/2002
TE Code
AB
On Market Since
2/3/2014
Pharmacological Classes
Price Statistics
The NADAC for ADDERALL 10 MG TABLET has been published 655 times since Mar 19, 2014, and over the history we have for it it has risen 167.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.1878 per EA |
|---|---|
| All-time high | $12.2247 (May 13, 2026) |
| All-time low | $4.4511 (Oct 22, 2014) |
| 52-week high | $12.2247 |
| 52-week low | $11.1482 |
| Median price | $7.1944 |
| Average price | $7.5986 |
| Largest weekly change | +9.4% (Jan 9, 2019) |
| Weeks tracked | 655 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADDERALL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADDERALL 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $12.1878 per EA (NDC 57844011001), effective Sep 30, 2026.
How has the price of ADDERALL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADDERALL 10 MG TABLET has risen 167.4%. It has been tracked across 655 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for ADDERALL 10 MG TABLET?
Since Mar 19, 2014, the NADAC for ADDERALL 10 MG TABLET has ranged from a low of $4.4511 (Oct 22, 2014) to a high of $12.2247 (May 13, 2026), with a median of $7.1944 per EA.
Are there cheaper alternatives to ADDERALL 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ADDERALL 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ADDERALL 10 MG TABLET?
ADDERALL 10 MG TABLET (NDC 57844011001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand (anda) product.
Is ADDERALL 10 MG TABLET in shortage?
Yes — NDC 57844011001 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).